These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10439233)

  • 1. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
    Olsen EA
    Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Walsh DS; Dunn CL; James WD
    Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
    [No Abstract]   [Full Text] [Related]  

  • 3. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M; Hayashi N; Igarashi A; Kitahara H; Maeguchi M; Mizuno A; Murata Y; Nogita T; Toda K; Tsuboi R; Ueki R; Yamada M; Yamazaki M; Matsuda T; Natsumeda Y; Takahashi K; Harada S
    Eur J Dermatol; 2004; 14(4):247-54. PubMed ID: 15319158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H; Kunte C
    MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 alpha-reductase and finasteride in pattern alopecia and acne.
    Burkhart CG; Burkhart CN
    J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
    Whiting DA
    Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
    Saraswat A; Kumar B
    Arch Dermatol; 2003 Sep; 139(9):1219-21. PubMed ID: 12975174
    [No Abstract]   [Full Text] [Related]  

  • 11. Finasteride--an update and review.
    Cather JC; Lane D; Heaphy MR; Nelson BR
    Cutis; 1999 Sep; 64(3):167-72. PubMed ID: 10500917
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group
    Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
    Shapiro J; Kaufman KD
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
    Tosti A; Iorizzo M; Vincenzi C
    Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
    [No Abstract]   [Full Text] [Related]  

  • 19. Female androgenetic alopecia treated by finasteride: a case forward.
    Valsecchi R; Leghissa P; Riva M
    Acta Derm Venereol; 2004; 84(6):488-9. PubMed ID: 15844649
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
    Kaufman KD; Rotonda J; Shah AK; Meehan AG
    Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.